Effect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial.
about
Update on the pharmacotherapy of cerebellar and central vestibular disordersPharmacological gating modulation of small- and intermediate-conductance Ca(2+)-activated K(+) channels (KCa2.x and KCa3.1)Consensus paper: management of degenerative cerebellar disorders.Pharmacotherapy of vestibular and cerebellar disorders and downbeat nystagmus: translational and back-translational research.Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus.Targeting potassium channels to treat cerebellar ataxia.
P2860
Effect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Effect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial.
@en
Effect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial.
@nl
type
label
Effect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial.
@en
Effect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial.
@nl
prefLabel
Effect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial.
@en
Effect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial.
@nl
P2093
P1433
P1476
Effect of chlorzoxazone in patients with downbeat nystagmus: a pilot trial.
@en
P2093
Erich Schneider
Jens Claaßen
Julian Teufel
Katharina Feil
Klaus Jahn
Roger Kalla
Roman Schniepp
Siegbert Krafczyk
Stanislavs Bardins
P304
P356
10.1212/WNL.0B013E3182A55F6D
P407
P577
2013-08-23T00:00:00Z